Status:
COMPLETED
Monitoring and Management for Metabolic Side Effects of Antipsychotics
Lead Sponsor:
VA Office of Research and Development
Conditions:
Mental Health
Psychotic Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test an approach for implementing guideline recommendations for assessing and managing metabolic side effects (including weight gain, diabetes, elevated lipids) in pati...
Detailed Description
Treatment of psychotic disorders consists primarily of antipsychotic medications, which are associated with metabolic side effects such as overweight/obesity, diabetes, and dyslipidemia. Expert consen...
Eligibility Criteria
Inclusion
- \- Providers involved in antipsychotic management or management of metabolic side effects and related conditions
Exclusion
- \- None
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01875861
Start Date
January 1 2011
End Date
April 1 2017
Last Update
February 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
North Little Rock, Arkansas, United States, 72114-1706